Cholesterol is essential for life. It is a structural component of cell membranes and the precursor of steroid hormones, bile acids, and vitamin D.
Cholesterol is insoluble in water. It must be transported through the bloodstream within lipoproteins.
Lipoproteins are transport vehicles, not cholesterol itself.
Every atherogenic lipoprotein contains one ApoB molecule. ApoB therefore reflects the number of particles capable of causing atherosclerosis.
Atherosclerosis begins when ApoB-containing lipoproteins become retained within the arterial wall.
Lifetime exposure to ApoB-containing particles is the major determinant of cardiovascular risk.
LDL cholesterol measures cholesterol mass. ApoB measures particle number. These measurements are related but not interchangeable.
Remnant lipoproteins and lipoprotein(a) also contribute to cardiovascular disease.
HDL participates in reverse cholesterol transport, but HDL cholesterol alone is not a reliable therapeutic target.
The liver is the central regulator of cholesterol homeostasis.
The LDL receptor is the body's principal mechanism for removing ApoB-containing lipoproteins from the circulation.
Most effective lipid-lowering therapies ultimately work by increasing hepatic clearance of ApoB-containing particles.
Statins, ezetimibe, PCSK9 inhibitors, bempedoic acid, and several newer therapies act through different mechanisms but share the same ultimate objective: reducing ApoB-containing lipoprotein exposure.
Insulin resistance increases production of triglyceride-rich lipoproteins, remnant particles, and small LDL particles, substantially increasing cardiovascular risk.
Lifestyle modification remains the foundation of cardiovascular prevention, regardless of pharmacologic therapy.
Early prevention provides greater benefit than late intervention.
Modern preventive cardiology focuses on reducing lifetime cardiovascular risk rather than simply treating elevated cholesterol values.
The ultimate goal is not achieving a laboratory number — it is preventing myocardial infarction, stroke, heart failure, disability, and premature death while preserving quality of life.
← The handbookTHE REFERENCE DESK
Key concepts.
Eighteen central ideas from The Lipoprotein & Cardiometabolic Handbook.